Our Services
Screening Tests
Women's Health
It's important for women to have regular health checks that can detect the presence of precancerous lesions. Book your PAP smear with us today.
Full Blood Count
A full blood count measures the concentration of red cells, white cells and platelets in the blood. This common test can be used to identify a wide range of illnesses, infection, and diseases.
Men's Health
It's important for men to have regular health checks that can screen for the presence of cancerous and non-cancerous tissue in the prostate gland. Book your PSA test with us today.
Cerba Lancet Kenya
Tests in the Catalogue
Number of Sites
Average Monthly Number of Tests
Average Monthly Number of Patients
Latest News
World Quality Week
2024 Newsletters | 2024-11-22
In medical diagnostic, the cornerstone of precision and reliability lies in quality assurance. Its practice is not merely a formality but a fundamental necessity that underpins the integrity and accuracy of the results. The highest standards of quality assurance are therefore paramount to safeguarding patient care and upholding the credibility of healthcare institutions.
BRCA Testing For Hereditary Breast Cancer
2024 Newsletters | 2024-11-07
Cancer occurs when cells in your body start to grow out of control. These cancer cells can multiply very quickly, cause growth or tumors, invade surrounding tissues, and even spread.(metastasize) to other areas of the body.
Heart Month
2024 Newsletters | 2024-09-18
1. What is Cardiovascular Disease (CVD)? CVD is a term that refers to any disease of the heart and blood vessels (including those of the brain).
Mpox Update 2024
2024 Newsletters | 2024-08-23
Mpox infection is caused by the monkeypox virus (MPXV), an enveloped double-stranded DNA virus of the Orthopoxvirus genus in the Poxviridae family. There are 2 distinct genetic clades, called clade I (formerly Central African clade) and clade II (formerly West African clade). Clade I is linked to more severe disease and a higher case fatality rate of approximately 10% (compared to 0.1% with clade II infections